Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 May:76 Suppl 1:S3-S55.
doi: 10.1016/S1297-319X(09)74520-8.

Abatacept therapy and safety management

Thao Pham  1 , Pascal Claudepierre, Arnaud Constantin, Bruno Fautrel, Laure Gossec, Jacques-Eric Gottenberg, Philippe Goupille, Eric Hachulla, Charles Masson, Jacques Morel, Alain Saraux, Thierry Schaeverbeke, Daniel Wendling, Xavier Mariette, Jean Sibilia
Affiliations
Review

Abatacept therapy and safety management

Thao Pham et al. Joint Bone Spine. 2009 May.

Abstract

Objectives: To elaborate a how-to-use abatacept material intended to help physicians in the management of patients with inflammatory diseases treated with this drug in routine practice.

Methods: 1) Selection of the relevant domains by a rheumatologists' panel; 2) Search for published evidence in each domain; 3) Elaboration of the clinical tool guide with a 3-level gradation of evidence (evidence-based medicine EBM, official recommendations and expert's opinion). The experts were 11 academic rheumatologists with a large experience in prescribing abatacept and in managing rheumatoid arthritis. They were all members of the CRI (Club Rhumatismes et Inflammation), a section of the French Rheumatology Society dedicated to the inflammatory rheumatic diseases. Each fact sheet was reviewed by two other experts; 4) Regular updating based on medical literature and postmarketing surveillance data.

Results: Four domains were considered relevant: abatacept contraindications, management of side effects or associated diseases appearing during abatacept treatment, management of "practical situations" such as surgery or pregnancy, physician and patient information. After the literature analysis and discussion during an experts' meeting, a consensus was reached on: a pre-treatment checklist aimed at searching abatacept contraindications; a what-to-do document when facing side effects or associated diseases (autoimmune pathology, bacterial or viral infections, cardiovascular diseases, intolerance to abatacept, solid or haematological malignancy) or "practical situations" (surgery, pregnancy, vaccination, travel, drug-drug interactions); an example of standard information letter to be addressed to the attending physician (rheumatologist and general practitioner); an example of standard information letter to be addressed to the patient.

Conclusion: Based on both an EBM approach and an expert's opinion approach, this abatacept clinical tool guide should provide assistance to all physicians attending patients treated with abatacept. For a better implementation in clinical practice, this tool guide will be available online at www.cri-net.com and regularly updated.

PubMed Disclaimer

Similar articles

  • Abatacept use in rheumatoid arthritis: evidence review and recommendations.
    Martín Mola E, Balsa A, Martínez Taboada V, Sanmartí R, Marenco JL, Navarro Sarabia F, Gómez-Reino J, Alvaro-Gracia JM, Román Ivorra JA, Lojo L, Plasencia C, Carmona L; Spanish expert panel of rheumatologists. Martín Mola E, et al. Reumatol Clin. 2013 Jan-Feb;9(1):5-17. doi: 10.1016/j.reuma.2012.05.001. Epub 2012 Jul 4. Reumatol Clin. 2013. PMID: 22766432 English, Spanish.
  • Use of abatacept in rheumatoid arthritis.
    von Kempis J, Dudler J, Hasler P, Kyburz D, Tyndall A, Zufferey P, Villiger PM. von Kempis J, et al. Swiss Med Wkly. 2012 May 11;142:w13581. doi: 10.4414/smw.2012.13581. eCollection 2012. Swiss Med Wkly. 2012. PMID: 22581564 Review.
  • Abatacept therapy and safety management.
    Pham T, Bachelez H, Berthelot JM, Blacher J, Claudepierre P, Constantin A, Fautrel B, Gaujoux-Viala C, Goëb V, Gossec L, Goupille P, Guillaume-Czitrom S, Hachulla E, Lequerré T, Marolleau JP, Martinez V, Masson C, Mouthon L, Puéchal X, Richette P, Saraux A, Schaeverbeke T, Soubrier M, Viguier M, Vittecoq O, Wendling D, Mariette X, Sibilia J. Pham T, et al. Joint Bone Spine. 2012 Mar;79 Suppl 1:3-84. doi: 10.1016/S1297-319X(12)70011-8. Joint Bone Spine. 2012. PMID: 22541956
  • TNF alpha antagonist therapy and safety monitoring.
    Pham T, Bachelez H, Berthelot JM, Blacher J, Bouhnik Y, Claudepierre P, Constantin A, Fautrel B, Gaudin P, Goëb V, Gossec L, Goupille P, Guillaume-Czitrom S, Hachulla E, Huet I, Jullien D, Launay O, Lemann M, Maillefert JF, Marolleau JP, Martinez V, Masson C, Morel J, Mouthon L, Pol S, Puéchal X, Richette P, Saraux A, Schaeverbeke T, Soubrier M, Sudre A, Tran TA, Viguier M, Vittecoq O, Wendling D, Mariette X, Sibilia J. Pham T, et al. Joint Bone Spine. 2011 May;78 Suppl 1:15-185. doi: 10.1016/S1297-319X(11)70001-X. Joint Bone Spine. 2011. PMID: 21703545
  • Tocilizumab: therapy and safety management.
    Pham T, Claudepierre P, Constantin A, de Bandt M, Fautrel B, Gossec L, Gottenberg JE, Goupille P, Guillaume S, Hachulla E, Masson C, Morel J, Puéchal X, Saraux A, Schaeverbeke T, Wendling D, Bruckert E, Pol S, Mariette X, Sibilia J; Club Rhumatismes et Inflammation (CRI). Pham T, et al. Joint Bone Spine. 2010 Jun;77 Suppl 1:S3-100. doi: 10.1016/S1297-319X(10)70001-4. Epub 2010 Jun 17. Joint Bone Spine. 2010. PMID: 20610315
See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources

-